Purchasing agent for Gleevec from India. Charitable purchasing agent for Gleevec from India. Purchasing agent for Gleevec from India. Purchasing agent for Imatinib from India.

If the WeChat consultation hotline cannot be reached, please add WeChat or our company promises: integrity-based, genuine goods at reasonable prices, selling conscientious medicines, cash on delivery, the ingredients and medicines of both the original Gleevec produced by the Indian Gleevec company and the Swiss Novartis company. What is the difference in effectiveness, and why are the prices of these two Gleevec so different? India itself is a country with a very developed generic drug industry. As soon as expensive drugs produced in Western countries are put on the market, under the protection of their own patent laws, India can imitate the same drugs, and the relative price will be several times lower. The Indian Gleevec Manufacturing Company????? Pharmaceutical Group is an Indian company The second largest pharmaceutical group, the effective content is stable, so users can take it with confidence. The price of the Swiss version of Gleevec is around ????, and the price of the genuine Indian Gleevec is ???? yuan (??? tablets per box). The price of the Indian Gleevec is only ???? of the Swiss Gleevec. , but the efficacy is the same. The low price and real efficacy of Indian Gleevec give cancer patients more hope. Therefore, Indian Gleevec is more suitable for our national conditions in China and is easier for the majority of patients to accept. Integrity sales of various anti-cancer drugs, India's Gleevec, India's Iressa? India's Nexavar, India's Tarceva. While ensuring the best quality, the price is as low as possible. Please negotiate with new and old patients for information. ?The company promises: honesty, genuine goods at reasonable prices, selling conscientious medicines, cash on delivery, ?Selling Gleevec from India: ????? Iressa from India: ???? Tarceva from India: ???? ? Functions and indications: Chronic myelogenous leukemia, gastrointestinal stromal tumors? Imatinib mesylate is the world’s first approved tumorigenesis-related signaling drug. Usage and dosage? Starting dose: For patients in the blast phase and accelerated phase of chronic myelogenous leukemia, the recommended dose of imatinib mesylate is? Patients with surgically resected or metastatic malignant gastrointestinal stromal tumors (????), children and adolescents: There is no clinical data on the safety and efficacy of imatinib mesylate treatment in patients under the age of ??. Dosage for patients with liver failure: The plasma concentration of imatinib mesylate may increase in patients with hepatic impairment, so these patients should be cautious when using this drug. Currently, there is no use of imatinib mesylate in patients with hepatic impairment. Based on the clinical data of imatinib, it is impossible to make recommendations for dose adjustment? Dosage in patients with renal failure and elderly patients: It is known that creatinine clearance can decrease with age, and age has no significant effect on the pharmacokinetics of imatinib mesylate. effects, as no clinical trials have been conducted in patients with renal impairment, no dose adjustment recommendations can be made